Using the canadian egg ladder in children with food protein-induced enterocolitis syndrome: a case series.

IF 2.6 4区 医学 Q2 ALLERGY Allergy Asthma and Clinical Immunology Pub Date : 2023-10-06 DOI:10.1186/s13223-023-00843-x
Linlei Ye, Tiffany Wong, Elana Lavine, Victoria E Cook, Stephanie C Erdle
{"title":"Using the canadian egg ladder in children with food protein-induced enterocolitis syndrome: a case series.","authors":"Linlei Ye, Tiffany Wong, Elana Lavine, Victoria E Cook, Stephanie C Erdle","doi":"10.1186/s13223-023-00843-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Current management of food protein-induced enterocolitis syndrome (FPIES) involves strict avoidance of the offending food for 12-18 months, followed by oral food challenge (OFC) under physician supervision. OFCs are resource-intensive and there is a lack of a universal standardized protocol for FPIES. Prolonged avoidance may increase the risk of IgE-mediated allergy, particularly in atopic patients. Food ladders have shown success in promoting accelerated tolerance in patients with IgE-mediated allergy. Our case series evaluated the safety of use of the Canadian Egg Ladder in patients with mild-to-moderate FPIES to egg.</p><p><strong>Methods: </strong>From May 2020 to November 2021, patients with mild-to-moderate FPIES to egg, defined as no history of lethargy or intravenous fluid administration, were started on the Canadian Egg Ladder. Instructions for advancing up the ladder were identical to using the Canadian Egg Ladder in patients with IgE-mediated allergy. Patients were followed every 3-6 months, at which time information was collected regarding progression up the ladder, symptoms while on treatment and interventions required. Treating allergists completed a survey to capture baseline demographic characteristics and prior tolerance to egg. Descriptive statistics were analyzed using MS Excel.</p><p><strong>Results: </strong>Twenty-one patients with mild-to-moderate FPIES were started on the Canadian Egg Ladder. Median age at initiation of the ladder was 10 months (IQR, 9-11). Nineteen (90.5%) patients completed the ladder, tolerating a serving size amount of cooked egg, over a median duration of 7 month (IQR, 4-9 months). Four patients (19.0%) had mild symptoms including vomiting (9.5%), pallor (9.5%), belching (4.8%), irritability (4.8%) and small spit up (4.8%). In three of the four patients, symptoms were the result of accidental exposure to a higher step of the ladder. There were no reports of lethargy. No patients required health care presentation or intravenous fluid administration. No patients discontinued the ladder.</p><p><strong>Conclusions: </strong>The Canadian Egg Ladder can safely guide the dietary advancement of egg-containing foods in patients with mild-to-moderate FPIES to egg, without the need for prolonged avoidance and resource-intensive OFCs.</p>","PeriodicalId":51302,"journal":{"name":"Allergy Asthma and Clinical Immunology","volume":"19 1","pages":"87"},"PeriodicalIF":2.6000,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy Asthma and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13223-023-00843-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Current management of food protein-induced enterocolitis syndrome (FPIES) involves strict avoidance of the offending food for 12-18 months, followed by oral food challenge (OFC) under physician supervision. OFCs are resource-intensive and there is a lack of a universal standardized protocol for FPIES. Prolonged avoidance may increase the risk of IgE-mediated allergy, particularly in atopic patients. Food ladders have shown success in promoting accelerated tolerance in patients with IgE-mediated allergy. Our case series evaluated the safety of use of the Canadian Egg Ladder in patients with mild-to-moderate FPIES to egg.

Methods: From May 2020 to November 2021, patients with mild-to-moderate FPIES to egg, defined as no history of lethargy or intravenous fluid administration, were started on the Canadian Egg Ladder. Instructions for advancing up the ladder were identical to using the Canadian Egg Ladder in patients with IgE-mediated allergy. Patients were followed every 3-6 months, at which time information was collected regarding progression up the ladder, symptoms while on treatment and interventions required. Treating allergists completed a survey to capture baseline demographic characteristics and prior tolerance to egg. Descriptive statistics were analyzed using MS Excel.

Results: Twenty-one patients with mild-to-moderate FPIES were started on the Canadian Egg Ladder. Median age at initiation of the ladder was 10 months (IQR, 9-11). Nineteen (90.5%) patients completed the ladder, tolerating a serving size amount of cooked egg, over a median duration of 7 month (IQR, 4-9 months). Four patients (19.0%) had mild symptoms including vomiting (9.5%), pallor (9.5%), belching (4.8%), irritability (4.8%) and small spit up (4.8%). In three of the four patients, symptoms were the result of accidental exposure to a higher step of the ladder. There were no reports of lethargy. No patients required health care presentation or intravenous fluid administration. No patients discontinued the ladder.

Conclusions: The Canadian Egg Ladder can safely guide the dietary advancement of egg-containing foods in patients with mild-to-moderate FPIES to egg, without the need for prolonged avoidance and resource-intensive OFCs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在儿童食物蛋白诱导的小肠结肠炎综合征中使用加拿大鸡蛋阶梯:一系列病例。
背景:目前对食物蛋白诱导的小肠结肠炎综合征(FPIES)的治疗包括在12-18个月内严格避免食用违规食物,然后在医生的监督下进行口服食物挑战(OFC)。OFC是资源密集型的,并且缺乏用于FPIES的通用标准化协议。长期回避可能会增加IgE介导的过敏风险,尤其是在特应性患者中。食物阶梯在促进IgE介导的过敏患者加速耐受方面取得了成功。我们的病例系列评估了在轻度至中度FPIES患者中使用加拿大蛋梯的安全性。方法:从2020年5月至2021年11月,在加拿大蛋梯上开始治疗轻度至中度FPIES至蛋,定义为无嗜睡或静脉输液史。在IgE介导的过敏患者中,向上爬的说明与使用加拿大蛋梯相同。每3-6个月对患者进行一次随访,收集有关进展、治疗期间的症状和所需干预措施的信息。治疗过敏症的专家完成了一项调查,以获取基线人口特征和先前对鸡蛋的耐受性。结果:21例轻度至中度FPIES患者开始接受加拿大蛋梯检查。阶梯开始时的中位年龄为10个月(IQR,9-11)。19名(90.5%)患者在中位持续时间为7个月(IQR,4-9个月)的时间内完成了阶梯,耐受一定份量的熟鸡蛋。4名患者(19.0%)症状轻微,包括呕吐(9.5%)、面色苍白(9.5%),打嗝(4.8%),易怒(4.8%。没有嗜睡的报告。没有患者需要医疗保健或静脉输液。没有病人停下梯子。结论:加拿大鸡蛋阶梯可以安全地指导轻度至中度FPIES患者将含鸡蛋食物的饮食发展为鸡蛋,而无需长期避免和资源密集型OFCs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
3.70%
发文量
96
审稿时长
12 weeks
期刊介绍: Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease. By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide. AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.
期刊最新文献
Introduction from the editors. Nasal food challenge with hen's egg white allergen. Inborn errors of immunity (primary immunodeficiencies). Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction. Retraction Note: Clinical and immuno-proteomic approach on lantana camara pollen allergy-a major health hazard.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1